The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study.

Karina KarinaLouis Martin ChristoffelRita NovarianiImam RosadiIis RoslianaSiti RosidahSiti SobariahNovy FatkhurohmanNurlaela PuspitaningrumYuli HertatiIrsyah AfiniDifky ErnandaTias WidyastutiA D SulaehaAlfida ZakiyahNoor AiniGrady KrisandiHubert Andrew

Published in: Scientifica (2021)

The use of aaPRP may prevent pulmonary fibrosis in severe COVID-19 patients through the reduction of patients' plasma IL-1β concentration and the amelioration of PaO2/FiO2 ratio.

Keyphrases

platelet rich plasma
pulmonary fibrosis
sars cov
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
early onset
prognostic factors
peritoneal dialysis
bone marrow
mesenchymal stem cells
patient reported outcomes